1) Recipe of the Day – Summer Berry Ice Cream, from the New York Times.

Have you ever made homemade Ice Cream?


Time: 10 minutes, plus churning and chilling

1 1/4 cups berries (blueberries, raspberries, strawberries, blackberries combined)

2 cups heavy cream

1/3 cup sugar, plus 2 tablespoons, as needed

1/8 teaspoon kosher salt

2 tablespoons vodka. (I assume the vodka is optional for diabetics like me) 

1. In a bowl, mash berries with a fork or potato masher until just slightly chunky.

2. In a saucepan over medium-low heat, bring cream to a simmer with 1/3 cup sugar and the salt. Taste berries and if they are very tart, add 2 tablespoons sugar to saucepan. Simmer, stirring occasionally, until sugar dissolves. Transfer to a bowl, stir in vodka and place in refrigerator or in an ice bath to chill.

3. When cold, pour mixture into ice cream machine. Add berries and churn according to manufacturer’s directions. Transfer to a container and freeze until solid, at least 2 hours. Let sit at room temperature for 5 to 10 minutes before serving, or in refrigerator for 15 to 30.

Yield: About a quart.

2) A music video of Scottish Folk singer Alasdair Roberts’ “Rhine River”, featuring the environmental art created by Andy Goldsworthy. 

For anyone who is a fun of art that uses what ever is found in a natural setting, I highly recommend watching the documentary “Rivers and Tides”, which shows Goldsworthy creating some of his work. I rented it through Netflix.


From the Wikipedia entry on Andy Goldsworthy:


Andy Goldsworthy, born July, 26, 1956, in Cheshire, England, is a British sculptor, photographer and environmentalist who produces site-specific sculpture and land art situated in natural and urban settings.  He uses natural, and found objects, to create both temporary and permanent sculptures, which draw out the character of their environment.

From the age of 13 he worked on farms as a labourer. He has likened the repetitive quality of farm tasks to the routine of making sculpture: “A lot of my work is like picking potatoes; you have to get into the rhythm of it.”

3) A New York Times Q and A post with Dr. David Dodick, of the Mayo Clinic, answering a question about  migraine treatments on the horizon.

I am very lucky to have never had a problem with headaches, let alone migraines.  If you do unfortunately get migraines, or have ever had a problem with them,  what kind of treatment do/did you get, and how successful is/was it?


Will more effective migraine treatments be available soon? Several are in development, says Dr. David Dodick of the Mayo Clinic, who has been responding to readers on the Consults blog.

Q. Dr. Dodick, my mom and I both suffer from debilitating migraines. For both of us, the triggers include bright light, barometric pressure change and stress. The major difference between the two of us, of course, is that she is 49 and I’m 19. My neurologists continue to guard against pumping me full of drugs other than the standard preventive variety (the Imitrex family).

You say new treatments are on the horizon. I guess my question is, what are they? And how open will access be to them in the next three years?
jcds42, Annapolis, Md.

A. Dr. David Dodick responds:

Triptans, like sumatriptan, or Imitrex, are so-called acute medications, taken as needed to relieve pain. Preventive medications are taken on a daily basis to prevent attacks, as well as reduce the severity and duration of attacks when they do occur. There are several new treatments, both acute and preventive, on the horizon which reflect a significant advance in our understanding of what’s happening in the brain during a migraine attack, and where it’s happening.

The real advance in acute medications is that they are not designed to constrict blood vessels, as many current medications do. Rather, they target different receptors on the surface of nerve cells that are involved in the transmission of pain and other symptoms that occur during a migraine attack. Therefore, individuals who have diseases affecting the blood vessels, including those with heart disease, should be able to use them.

In addition, new preventive medications have been designed and are being tested specifically for migraine. In the past, many of the medications used to prevent migraines were designed to treat another disorder, like depression, high blood pressure or epilepsy, then found to be effective for migraine.

Finally, nondrug therapies, including transcranial magnetic stimulation using a hand-held device, is emerging as a possibly effective acute treatment for migraine with aura. Hopefully, some of these treatments will be available within the next three to five years.